LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,441 pages found matching data breach- Reviewing ADHD Drugs - FDA Goes Through the Motions
Mar-12-06 Some of the top-selling drugs of all time are those prescribed to treat attention deficit disorders. Drug companies have physicians in every field of medicine pushing these medications and dole out millions of dollars worth of free samples each year to make sure they are passed out like candy. A new ADHD drug is set to come on the market that supposedly c... - Life After Depo-Medrol - Sheer Hopeless Hell
Mar-10-06 Complaining of a sudden localized hip pain, in January 2002, Dennis Capolongo, was diagnosed with a disc herniation and given 2 epidural injections of the steroid Depo-Medrol that resulted in two trips to the ER, a stint in the hospital, and horrific back pain that continued nonstop for months. A short time later, when reviewing his original MRIs, new doc... - Genentech and Biogen Legal Troubles - When It Rains It Pours
Mar-7-06 Rituxan gained FDA approval in 1997, as a treatment for a certain type of non-Hodgkin's lymphoma. Roughly 12,760 patients in the US have the form of cancer Rituxan was approved to treat. Yet by 2005, sales of the drug grew to $1.8 billion in the US. A lawsuit filed by a former Rituxan salesman explains how this happened. On January 11, 2006, Dow Jones r... - Rod Stewart Cancelled Concert Settlement (Mar-07-06)
The rock star was advanced $2 million to perform a New Year's concert at the Rio hotel casino in Las Vegas in 2000. Stewart cancelled the concert due to throat surgery but allegedly failed to repay his advance. Harrah's Entertainment filed a lawsuit against Stewart alleging breach of contract. A federal judge ordered Stewart to pay Harrah's a $3 million... - Interview with an Insurance Advocate
Mar-1-06 J. D. Howard knows about insurance. He spent 40 years in the insurance claims field and knows just about every trick in the book - by insurance companies. Since 1965, he worked as an adjustor and insurance advocate in and around Phoenix and retired in 1994, but not for long. "I was sick and tired of watching Oprah, then one of my sons showed me the powe... - Tysabri Clinical Trial - Woman Misdiagnosed With MS Dies
Mar-1-06 It's always about money. Despite an annual cost of $23,500, initial sales of Tysabri were booming. As a once-a-month drug administered by a doctor, it received fast-track approval in late 2004. When it was withdrawn from the market 3 months later, 5,000 patients were on it and 15,000 more were awaiting insurance verification for the first dose. Biogen Ide... - FDA Grants Guinea Pig Status To US Citizens
Feb-28-06 "It is outrageous that, for all intents and purposes, the FDA allowed a clinical trial to proceed, which makes every citizen in the United States a potential "guinea pig," without providing a practical, informative warning to the public." The statement of outrage above was included in a letter to acting FDA Commissioner, Dr von Eschenbach, from Senator Ch... - Off-Label Use Of Lilly's Evista Multiplies Risks
Feb-26-06 On October 24, 2002 the Cancer Prevention Coalition issued a press release that said women taking the osteoporosis drug Evista, marketed since 1997 by Eli Lilly, were at an increased risk of developing ovarian cancer. "There is ample scientific evidence that Evista poses risks of ovarian cancer," wrote Samuel Epstein, MD, Chairman of the Prevention Coalit... - Psych Drugs - Doctors Serve As Middle-Man Pushers
Feb-21-06 Although peddling psychiatric drugs for off-label treatment of every ailment known to man is highly profitable, it is also illegal. Marketing schemes that increase the rates at which drugs are prescribed for off-label use, result in the sale of drugs that have not been proven safer or superior to FDA approved medications already on the market. That said,... - Zyprexa Medicaid Gravy Train Derailed
Feb-20-06 When Zyprexa was approved to treat adults with schizophrenia in 1996, Eli Lilly and the FDA knew about the drug's lethal side effects. Data from a 1996 six-week clinical trial revealed 27 deaths, 15 of which were suicides, and a drop-out rate of 65%. In his book, Mad In America, investigative journalist Robert Whitaker, reported that one in every 145... - Mirapex - Two Victims - Same Horror Story
Feb-16-06 In mid-2001, Joe Neglia went on a cruise to Alaska and that trip marked the beginning of his downward spiral into hell. The ship had a gambling casino on board and according to Joe, he was "instantly and savagely hooked on the slots." A major problem arose when he came back ashore. "When I returned from the cruise I began hitting the local casinos," he re... - Strattera - 130 Reports Of Suicidality In One Month
Feb-15-06 A not yet released discussion paper written by the British Medicines and Healthcare Regulatory Agency, reveals that last fall, there were 130 reports of suicidality in a single month by patients treated with the attention deficit drug Strattera. In addition, the paper reveals that there have also been more than 760 spontaneous reports of cardiac disorders... - ADHD Drugs - Cash Cow For Pharma
Feb-13-06 "Our society viewed with loathing those who 'pushed' stimulant drugs on children," says child psychiatrist Dr Peter Breggin. "Yet today, there are more children taking Ritalin and amphetamines from doctors than ever received them from illegal pushers," he says. "Parents and teachers and even doctors have been badly misled by drug company marketing practic... - Trasylol Blamed For Lethal Injuries During Surgery
Feb-10-06 Experts are sounding the alarm that patients who received the drug Trasylol (generic aprotinin), during a surgical procedure may have suffered kidney failure, a heart attack, heart failure, or a stroke as an adverse event caused by the drug. The results of a study, published last month in the New England Journal of Medicine, by the independent, non-commer... - Vaccinating For Profit - From Cradle to Coffin
Feb-2-06 Due to the flooding of special education classrooms, along with the rising medical costs of treating injured children, local taxes will soon go through the roof, at which time the public will be forced to face the unthinkable truth about the poisoned generation. And when that happens, government officials had better not even think about trying to feign i... - Natrecor Heart Drug - Deadly and Expensive
Jan-31-06 Let there be no mistake, Johnson & Johnson, and its subsidiary Scois, knew all about the dangers associated with its heart failure drug Natrecor, but threw caution to the wind in promoting its off-label use in pursuit of profits. Natrecor was FDA approved in August 2001 for the sole purpose of treating patients for the most acute from of congestive heart... - Doubleday Dilemma
Jan-27-06 A third lawsuit has been filed in a Seattle federal court against the best-selling author James Frey. In the wake of the discovery by The Smoking Gun , an investigative Web site, alleging that Frey fabricated some information in his book, A Million Little Pieces , Doubleday, a division of Random House, the book's publisher, issued a statement promising... - Drug Marketing Scheme Hits Nation's School System
Jan-26-06 TeenScreen, the elaborate drug marketing scheme concocted by the pharmaceutical industry and a front group operating out of Columbia University, is being promoted by the Bush administration's recommendation to screen the nation's school population for mental illness. The Bush appointed New Freedoms Commission on Mental Health issued a report in July 2003... - Silzone valves linked to Stroke and Adverse Side Effects
Jan-26-06 The St. Jude Silzone valve has now been withdrawn from the market but not before 36,000 Silzone coated heart valves had been implanted in patients throughout the world. Silver coating of the sewing ring (Silzone) was introduced as a modification of the St Jude Medical standard valve to provide antibacterial protection. The recall followed reports of u... - ADHD Medications could prove Deadly
Jan-5-06 A report was issued today by the FDA stating that cases of sudden death and serious side effects including hypertension, heart attack and stroke have been linked in association with therapeutic doses of drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. The FDA Advisory Committee further says that "...